ArticleJournal of Cancer2019

MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2.

Bo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.